Validation of the Psoriatic Arthritis Impact of Disease (PsAID) Questionnaire and its potential as a single-item outcome measure in clinical practice

Article info

Clinical and epidemiological research

Extended report

Richard Holland Royal National Hospital for Rheumatic Diseases, Royal United Hospitals, Bath, UK RPAH Medical Centre, Newtown, Sydney, NSW, Australia PubMed articles Google scholar articles
William Tillett Royal National Hospital for Rheumatic Diseases, Royal United Hospitals, Bath, UK Department of Pharmacy and Pharmacology, University of Bath, Bath, UK PubMed articles Google scholar articles
Eleanor Korendowych Royal National Hospital for Rheumatic Diseases, Royal United Hospitals, Bath, UK PubMed articles Google scholar articles
Charlotte Cavill Royal National Hospital for Rheumatic Diseases, Royal United Hospitals, Bath, UK PubMed articles Google scholar articles
Nicola Waldron Royal National Hospital for Rheumatic Diseases, Royal United Hospitals, Bath, UK PubMed articles Google scholar articles
Melanie Brooke Royal National Hospital for Rheumatic Diseases, Royal United Hospitals, Bath, UK PubMed articles Google scholar articles
Neil J McHugh Royal National Hospital for Rheumatic Diseases, Royal United Hospitals, Bath, UK Department of Pharmacy and Pharmacology, University of Bath, Bath, UK PubMed articles Google scholar articles

Correspondence to Dr Richard Holland, RPAH Medical Centre, Newtown, Sydney, NSW, Australia; drrichardholland{at}gmail.com

Citation

Holland R, Tillett W, Korendowych E, et al

Validation of the Psoriatic Arthritis Impact of Disease (PsAID) Questionnaire and its potential as a single-item outcome measure in clinical practice

Annals of the Rheumatic Diseases 2018;77:343-347.

Online issue publication

April 09, 2023